Log In
BCIQ
Print this Print this
 

CERC-406

  Manage Alerts
Collapse Summary General Information
Company Cerecor Inc.
DescriptionCatechol-O-methyl-transferase (COMT) inhibitor
Molecular Target Catechol-O-methyl-transferase (COMT)
Mechanism of ActionCatechol-O-methyl-transferase (COMT) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationCognitive dysfunction
Indication DetailsTreat residual cognitive impairment symptoms in patients with major depressive disorder (MDD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today